Who invested in Bambusa Therapeutics?
Bambusa Therapeutics's investors include RA Capital Management, Janus Henderson Investors, Invus and Redmile Group.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$90Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Source recordedSEC filing: $9.0M sold, first sale Jun 2024
From Bambusa Therapeutics's own website: 1 founder, 6 on the team.
AdvisersLooking Forward
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Bambusa Therapeutics's investors include RA Capital Management, Janus Henderson Investors, Invus and Redmile Group.
Bambusa Therapeutics has raised $90M across 2 rounds since 2025. One round did not disclose an amount, so the total is a floor.
Bambusa Therapeutics's most recent round was a Venture in Nov 2025.
Bambusa Therapeutics's largest round on record is $90M (Series A), in Feb 2025.
Bambusa Therapeutics's first round on record, in Feb 2025, was backed by RA Capital Management, Janus Henderson Investors and Invus and 1 others.
Bambusa Therapeutics's latest named round is a Venture, in Nov 2025.
Bambusa Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.